41. CÁTEDRA SANTIAGO GRISOLÍA INTERNATIONAL SYMPOSIUM ON HYPERAMMONEMIA AND hepatic encephalopathy November1417, 2004 – Valencia (Spain). PRELIMINARY PROGRAM NEUROTRANSMISSION http://www.cac.es/fundacion/symposiuminf2004.htm

INTERNATIONAL SYMPOSIUM ON HYPERAMMONEMIA AND HEPATIC ENCEPHALOPATHY PRELIMINARY PROGRAM NEUROTRANSMISSION Jan Albrecht Prevention of ammonia neurotoxicity by exo- and endogenous neurotransmitter receptor ligands Pilar Monfort Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia and hepatic failure Christopher Rose Glutamate release mechanisms in hyperammonemia Protein tyrosine nitration in hyperammonemia and hepatic encephalopathy Violina Lozeva-Thomas Alterations in histaminergic neurotransmission in liver disease Roger F. Butterworth Neurosteroids in HE: the missing link? BRAIN METABOLISM IN HYPERAMMONEMIA AND LIVER FAILURE STUDIED BY NMR Claudia Zwingmann Brain metabolism in experimental models of acute and chronic liver failure by 13C-NMR Transfer of reducing equivalents in neurons and glia of the hyperammonemic brain as detected by 13C-2H NMR PATHOPHYSIOLOGY OF BRAIN EDEMA AND HEPATIC ENCEPHALOPATHY IN LIVER FAILURE Michael D. Norenberg

42. CCHS Clinical Digital Library hepatic encephalopathy Clinical Resources. Chapter 154 Acute and ChronicLiver Failure and hepatic encephalopathy Access document. http://cchs-dl.slis.ua.edu/clinical/gastroenterology/hepatic/hepatic/hepatic_enc

Clinical Resources by Topic: Gastroenterology Hepatic Encephalopathy Clinical Resources Emergency Pediatrics Pathology Clinical Guidelines ... Miscellaneous Resources See also: Gastrointestinal Clinical Procedure Resources General Gastroenterology Clinical Resources Harrison's Principles of Internal Medicine 15th Ed.-2001: Table of contents Health Sciences Library subscription INFO Chapter 292: Approach to the Patient with Liver Disease Table of contents Introduction: Access document Liver Structure and Function: Access document Liver Diseases: Access document Clinical History: Access document Physical Examination: Access document Laboratory Testing: Access document Diagnostic Imaging: Access document Liver Biopsy: Access document Chapter 299: Cirrhosis and its Complications: Table of contents Introduction: Access document Major Complications of Cirrhosis: Access document Introduction: Access document Hepatic Encephalopathy: Access document Treatment: Access document Chapter 376: Critical Care Neurology: Table of contents Critical Care Disorders of the Central Nervous System Associated with Systemic Disease: Access document Metabolic Encephalopathies: Access document Feldman: Sleisenger and Fordtran's Gastrointestinal and Liver Disease 7th Ed.-2002 (MD Consult):

43. Do Ammonia Levels Correlate With Hepatic Encephalopathy? - October 1, 2003 - Ame Do Ammonia Levels Correlate with hepatic encephalopathy? hepatic encephalopathyin patients with chronic liver dysfunction is believed http://www.aafp.org/afp/20031001/tips/8.html

Advanced Search Tips from Other Journals Previous Next Do Ammonia Levels Correlate with Hepatic Encephalopathy? Consecutive patients who were admitted to a tertiary care center with the diagnosis of cirrhosis between September 1998 and December 1999 were enrolled in the study. The diagnosis of cirrhosis was established by biopsy or by signs of portal hypertension such as gastroesophageal varices, previous variceal bleeding, or ascites. Researchers collected clinical and laboratory data at the time of admission. The mental status of the patients was assessed using the West Haven Criteria for grading of mental status (see the accompanying table) . A diagnosis of hepatic encephalopathy was established when the patients' mental status was altered and other causes of mental status changes had been excluded. After diagnosis, fasting arterial and venous blood samples were obtained, and total ammonia and partial pressure of ammonia were determined. West Haven Criteria for Grading of Mental Status The rightsholder did not grant rights to reproduce this item in electronic media. For the missing item, see the original print version of this publication.

44. Advances In Cirrhosis, Hyperammonemia, And Hepatic Encephalopathy|KLUWER Academi Books » Advances in Cirrhosis, Hyperammonemia, and hepatic encephalopathy. Advancesin Cirrhosis, Hyperammonemia, and hepatic encephalopathy. Add to cart. http://www.wkap.nl/prod/b/0-306-45598-6

Title Authors Affiliation ISBN ISSN advanced search search tips Books Advances in Cirrhosis, Hyperammonemia, and Hepatic Encephalopathy Advances in Cirrhosis, Hyperammonemia, and Hepatic Encephalopathy Add to cart edited by Vicente Felipo Book Series: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY Volume 420 Contents and Contributors Kluwer Academic/Plenum Publishers Hardbound, ISBN 0-306-45598-6 August 1997, EUR 169.00 / USD 186.00 / GBP 117.00 Home Help section About Us Contact Us ... Search

45. Cirrhosis, Hepatic Encephalopathy And Ammonium Toxicity|KLUWER Academic Publishe Books » Cirrhosis, hepatic encephalopathy and Ammonium Toxicity.Cirrhosis, hepatic encephalopathy and Ammonium Toxicity. edited http://www.wkap.nl/prod/b/0-306-43666-3

Title Authors Affiliation ISBN ISSN advanced search search tips Books Cirrhosis, Hepatic Encephalopathy and Ammonium Toxicity Cirrhosis, Hepatic Encephalopathy and Ammonium Toxicity edited by Instituto de Investigaciones, Citologicas de la F.I.B., Valencia, Spain Vicente Felipo Instituto de Investigaciones Citologicas de la Caja de Ahorres de Valencia, Spain Book Series: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY Volume 272 Kluwer Academic/Plenum Publishers Hardbound, ISBN 0-306-43666-3 May 1991, 284 pp. Out of print Home Help section About Us Contact Us ... Search

46. Neurological Disorders, Brain Diseases, Metabolic, Hepatic Encephalopathy Submit Your Site to the hepatic encephalopathy category. Sponsored hepatic encephalopathySites. Submit Your Site to the hepatic encephalopathy category. http://www.iseekhealth.com/hepatic_encephalopathy-1955.php

Home About Us Contact Submit Your Site Search : Home Health Conditions and Diseases Neurological Disorders ... Hepatic Encephalopathy More Hepatic Encephalopathy Categories: Submit Your Site to the Hepatic Encephalopathy category Sponsored Hepatic Encephalopathy Sites Brain Disease. Is It Alzheimer's? Alzheimer's is a disease of the brain. It makes it hard for people to remember, think, and use language. It can also make it difficult to do daily tasks like using the phone and cooking. But early treatment may help. Learn how to spot early symptoms. Fully searchable traditional medicine and alternative medicine books, videos and products for doctors, students and the public. An affiliate of Amazon.com. PCBs May Cause Brain Damage and Memory Problems Because PCBs damage the thyroid gland, scientists believe PCBs may damage the brain and cause memory problems, along with altered thyroid hormone levels. FpNotebook: Hepatic Encephalopathy - Offers participating factors, pathophysiology, symptoms and signs, diagnosis and management. WebMD/Lycos: Hepatic Encephalopathy - An in depth look at this disorder, from alternative names to a description, causes, incidence and risk factors, symptoms, diagnosis, treatment, prognosis, complications and prevention.

47. Hepatic Encephalopathy - Humana Press hepatic encephalopathy Pathophysiology and Treatment. Butterworth, RogerF. (Hôpital SaintLuc, Montréal, CANADA) Layrargues, Gilles http://www.humanapress.com/Product.pasp?txtCatalog=HumanaBooks&txtProductID=0-89

48. Nonabsorbable Disaccharides For Hepatic Encephalopathy (Cochrane Review) All rights reserved. Nonabsorbable disaccharides for hepatic encephalopathy(Cochrane Review). AlsNielsen B, Gluud LL, Gluud C. ABSTRACT. http://www.cochrane.org/cochrane/revabstr/ab003044.htm

From The Cochrane Library, Issue 2, 2004 Nonabsorbable disaccharides for hepatic encephalopathy (Cochrane Review) Als-Nielsen B, Gluud LL, Gluud C ABSTRACT Order full review View and/or submit comments What's new in this issue Search abstracts ... Browse by Review Group A substantive amendment to this systematic review was last made on 11 February 2004. Cochrane reviews are regularly checked and updated if necessary. Background: Nonabsorbable disaccharides (lactulose or lactitol) are considered the treatment of choice for hepatic encephalopathy. Objectives: To assess the beneficial and harmful effects of nonabsorbable disaccharides for patients with hepatic encephalopathy. Search strategy: Trials were identified through The Cochrane Hepato-Biliary Group Controlled Trials Register (March 2003), The Cochrane Central Register of Controlled Trials (Issue 1, 2003), MEDLINE (1966 to 2003/03), EMBASE (1980 to 2003/03), manual searches of bibliographies and journals, authors of trials, and pharmaceutical companies. Selection criteria: Randomised trials comparing lactulose or lactitol versus no intervention, placebo, or antibiotics and trials comparing lactulose versus lactitol for hepatic encephalopathy.

49. Benzodiazepine Receptor Antagonists For Hepatic Encephalopathy (Cochrane Review) All rights reserved. Benzodiazepine receptor antagonists for hepatic encephalopathy(Cochrane Review). AlsNielsen B, Gluud LL, Gluud C. ABSTRACT. http://www.cochrane.org/cochrane/revabstr/ab002798.htm

From The Cochrane Library, Issue 2, 2004 Benzodiazepine receptor antagonists for hepatic encephalopathy (Cochrane Review) Als-Nielsen B, Gluud LL, Gluud C ABSTRACT Order full review View and/or submit comments What's new in this issue Search abstracts ... Browse by Review Group A substantive amendment to this systematic review was last made on 23 February 2004. Cochrane reviews are regularly checked and updated if necessary. Background: Hepatic encephalopathy may be associated with accumulation of substances that bind to a receptor-complex in the brain resulting in neural inhibition. Benzodiazepine receptor antagonists may have a beneficial effect on patients with hepatic encephalopathy. Objectives: To evaluate the beneficial and harmful effects of benzodiazepine receptor antagonists for patients with hepatic encephalopathy. Search strategy: Eligible trials were identified through The Cochrane Hepato-Biliary Group Controlled Trials Register, The Cochrane Controlled Trials Register on The Cochrane Library, MEDLINE and EMBASE (last search: January 2004), reference lists of relevant articles, authors of trials, and pharmaceutical companies. Selection criteria: Randomised trials comparing any benzodiazepine receptor antagonist versus placebo or no intervention for hepatic encephalopathy.

50. Disease - Hepatic Encephalopathy - Hartford, Connecticut , Saint Francis Care Disease hepatic encephalopathy - courtesy of Saint Francis Care of Hartford, Connecticut,contemporary medicine with major clinical concentrations in heart http://www.saintfranciscare.com/12340.cfm

@import url(main.css); About Us Health Information Adam Article Manager CareMail Signup ... Ways To Help Adam Article Manager Back Back to main Health Information page Disease - Hepatic encephalopathy Digestive system organs Definition: Hepatic encephalopathy is brain and nervous system damage that occurs as a complication of liver disorders. It is characterized by various neurologic symptoms including changes in reflexes, changes in consciousness , and behavior changes that can range from mild to severe. Alternative Names: Hepatic coma; Encephalopathy - hepatic Causes And Risk: Hepatic encephalopathy is caused by disorders affecting the liver. These include disorders that reduce liver function (such as cirrhosis or hepatitis ) and conditions where blood circulation bypasses the liver. The exact cause of the disorder is unknown. However, when the liver cannot properly metabolize and detoxify substances in the body, toxic substances build up in the bloodstream. One substance believed to be particularly toxic to the central nervous system is ammonia , which is produced by the body when proteins are digested, but is normally detoxified by the liver. Many other substances may also accumulate in the body and contribute to damage to the nervous system.

51. Probiotic Treatment Effective In Minimal Hepatic Encephalopathy Probiotic Treatment Effective in Minimal hepatic encephalopathy CME. News AuthorLaurie Barclay, MD CME Author Désirée Lie, MD, MSEd Authors and Disclosures. http://www.medscape.com/viewarticle/477736

52. Www.medscape.com/viewarticle/477736?rss hepatic encephalopathy http://www.medscape.com/viewarticle/477736?rss

53. HerbChina2000.com - Herbal Remedies - Hepatic Encephalopathy hepatic encephalopathy, DESCRIPTION Altered mental and neuromotorfunctioning associated with acute orchronic liver disease and/or http://www.herbchina2000.com/therapies/DHE.shtml

Home Hepatic encephalopathy DESCRIPTION Altered mental and neuromotor functioning associated with acute orchronic liver disease and/or portal systemic shunting of blood. The prominent features are mild to marked forgetfulness, impaired arousability, and a "flapping tremor" (asterixis). SYNONYMS Hepatic coma Liver coma SYMPTOMS Age 10-60 Prominent signs of underlying liver disease (50%), jaundice most common. ascites secon most common Gastrointestinal hemorrhage with hematemesis or melena (20%) Systemic infection, urinary tract or pulmonary (20%) Four stages of confusion and obtundity described. (1). forgetfulness, disturbance in nocturnal sleep, daytime droesiness, (2). mild confusion but arousability, (3). arousable, but markedly confusion, limited orientation and thought content, (4). unarousable. Asterixis prominent in stages 2, 3

54. Medical Encyclopedia Disease hepatic encephalopathy. Definition hepatic encephalopathy is brain andnervous system damage that occurs as a complication of liver disorders. http://www.medstarhealth.org/body.cfm?id=124&action=display&articlenum=302

55. Medical Encyclopedia Disease hepatic encephalopathy. Definition hepatic encephalopathy is brain andnervous system damage that occurs as a complication of liver disorders. http://www.georgetownuniversityhospital.org/body.cfm?id=18&action=display&articl

56. Synbiotic Modulation Of Gut Flora Improves Minimal Hepatic Encephalopathy In Cir Synbiotic modulation of gut flora improves minimal hepatic encephalopathyin cirrhotic patients. Signs of liver disease also improve http://www.eurekalert.org/pub_releases/2004-05/jws-smo051304.php

Public release date: 13-May-2004 Contact: David Greenberg dgreenbe@wiley.com Synbiotic modulation of gut flora improves minimal hepatic encephalopathy in cirrhotic patients Signs of liver disease also improve in conjunction with alterations to gut flora Some cirrhotic patients develop brain dysfunction, called hepatic encephalopathy, which causes deficits in behavior, intelligence, consciousness and neuromuscular function. When the dysfunction is minor, it is called minimal hepatic encephalopathy (MHE). Since ammonia has been shown to play a key role in overt hepatic encephalopathy, treatment options for MHE have also focused on reducing ammonia levels in the body. A new study published in the May 2004 issue of Hepatology has shown that treating cirrhotic patients with synbiotics or fermentable fiber can alter the flora in the gut, lowering its pH levels as well as the ammonia levels in the blood. Both treatments improved clinical signs of brain and liver dysfunction. They may be useful alternatives to lactulose for the management of MHE. http://www.interscience.wiley.com/journal/hepatology

57. Details For Advances In Cirrhosis, Hyperammonemia, And Hepatic Encephalopathy Advances in Cirrhosis, Hyperammonemia, and hepatic encephalopathy Proceedings ofan International Symposium, Held in Valencia, Spain, December 24, 1996 Felipo http://www.bmjbookshop.com/shop/product_display.asp?productid=0306455986&product

58. Defective Memory Function In Early Hepatic Encephalopathy -- Hepatitis C Outreac Subject Defective memory function in early hepatic encephalopathy.Author Weissenborn K, et al; Journal of Hepatology 2003; 39(3 http://www.voy.com/17059/416.html

Contribute: Reserve your VoyUser name No-ads: Completely remove ads from your forum Owner Login VoyForums Homepage Create a New Forum VoyForums News Help Desk VoyForums Exchange FAQ - Frequently Asked Questions Directory/Categories Search VoyForums VoyUser Login Wed, June 02 2004, 14:12:34 PDT VoyUser Login optional Main index Post a new message Check update time Archives: Subject: Defective memory function in early hepatic encephalopathy Author: Weissenborn K, et al; Journal of Hepatology 2003; 39(3): 320-5 (September 2003) Next Thread Previous Thread Next Message Previous Message Date Posted: Fri, August 15 2003, 10:41:34 PDT In reply to: H. Aaron Aronow,MD Neurology and Internal Medicine USC .. 's message, Neurological manifestation of HCV on Sat, May 19 2001, 10:27:06 PDT Defective memory function in early hepatic encephalopathy A study in the September issue of The Journal of Hepatology finds that although patients with early hepatic encephalopathy score lower than controls in memory tasks, this is predominantly due to deficits in attention and visual perception.

59. Branched-chain Amino Acids For Hepatic Encephalopathy (Cochrane Review) All rights reserved. Branchedchain amino acids for hepatic encephalopathy (CochraneReview). Our primary outcome was improvement of hepatic encephalopathy. http://www.update-software.com/abstracts/AB001939.htm

From The Cochrane Library, Issue 2, 2004 Branched-chain amino acids for hepatic encephalopathy (Cochrane Review) Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C ABSTRACT Order full review View and/or submit comments What's new in this issue Search abstracts ... Browse by Review Group A substantive amendment to this systematic review was last made on 19 September 2002. Cochrane reviews are regularly checked and updated if necessary. Background: Hepatic encephalopathy may be caused by a decreased plasma ratio of branched-chain amino acids (BCAA) to aromatic amino acids. Treatment with BCAA may therefore have a beneficial effect on patients with hepatic encephalopathy. Objectives: To evaluate the beneficial and harmful effects of BCAA for patients with hepatic encephalopathy. Search strategy: We identified trials through The Cochrane Hepato-Biliary Group Controlled Trials Register (September 2002), (Issue 3, 2002), MEDLINE (1966-2002/09) and EMBASE (1980-2002/05), manual searches of bibliographies and journals, authors of trials, and pharmaceutical companies. Selection criteria: Randomised trials comparing BCAA with any kind of control therapy for hepatic encephalopathy were included, regardless of blinding, language, or publication status.

60. NEJM -- Sign In Correspondence from The New England Journal of Medicine Management ofhepatic encephalopathy. Next Next. Management of hepatic encephalopathy. http://content.nejm.org/cgi/content/full/337/26/1921-a

HOME SEARCH CURRENT ISSUE PAST ISSUES ... HELP Access to this article requires sign-in. Subscribers have access to all content. Other registered users have access to research articles six months old and older. If you're a registered user or an activated subscriber SIGN IN User Name Password Forgot your Password? Click here and we'll e-mail it to you. If you do not use cookies, sign in here. Remember my User Name and Password. PURCHASE THIS ARTICLE Purchase a single article and get immediate online access for just $10. If you're a subscriber but have not yet activated your full online access If you'd like to purchase a subscription to NEJM If you're not a subscriber and want FREE limited access... ACTIVATE YOUR SUBSCRIPTION Subscribers to NEJM are entitled to full access to all online content and features, including 20 FREE online CME exams. OR Receive full access to ALL current content and online features including Personal Archives, PDF article downloads, PDA access, E-mail alerts and 20 FREE online CME exams. OR Receive FREE online access to NEJM Original and Special Articles 6 months after publication and choose to receive the Table of Contents and notification of early release articles via e-mail.

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 3     41-60 of 93    Back | 1  | 2  | 3  | 4  | 5  | Next 20